Invea Therapeutics, Inc.
1 known investors
Invea Therapeutics is a biotechnology company developing small molecule oral therapies for immune-mediated inflammatory diseases using artificial intelligence and machine learning to understand inflammation mechanisms. The company targets patients with chronic IMIDs through innovative drug candidates including lead program INVA8001.
AI & Machine LearningBiotech